Jeeva Informatics eClinical Platform Improves Trials
The founder and CEO of Jeeva Informatics, Harsha Rajasimha, maintains that clinical trials are held back by inefficiency and inadequate [...]
African Biotech Conversations: New Podcast by Adrienne Leussa
In the first episode of the podcastAfrican Biotech Solutions, Adrienne Leussa, PhD biochemist in South Africa, interviews Chris Connor, the [...]
Insurance Design Harms Patient Health with Barriers to Access
Patient health is harmed by barriers to access caused by Insurance design, according to The Pharmaceutical Research and Manufacturers of [...]
Are Mammograms After 75 Worth It?
Uncertainty is building regarding the value of mammograms for breast cancer screening after 75 years of age according to a [...]
CADTH Annual Report 2020–2021
The theme of the Canadian Agency for Drugs and Technologies in Health’s (CADTH) annual report for 2020-2021 was “unprecedented.” The [...]
Establishing the Value of Next-Gen Sequencing
Next-generation sequencing (NGS) has been touted by some as the backbone of future precision medicine approaches. This technology could help [...]
Machine Learning Best Practices – USA, Canada, and UK Propose 10 Guiding Principles
Machine learning and artificial intelligence-based medical devices are being approved with increasing frequency but lack established best practices. As a [...]
2022 Predictions: Ezekiel Emanuel Fireside Chat
Image by: Samuel Masinter (CC by 3.0) On Wednesday, December 1st, 2021, esteemed oncologist and policymaker Dr. Ezekiel [...]
ISPOR Boosts HEOR in Low & Middle-Income Countries
ISPOR pledged to promote HEOR efforts in low- to middle-income countries (LMICs) in its Strategic Plan 2024. LMICs often face [...]
Machine Learning to Predict Reentry Rates Using Hospital RWE
Machine learning, an advanced automated data analysis method, may predict 30-day hospital readmission rates, according to a report published [...]
PhRMA President Introduces Recipients of 2020 Challenge Award, Emphasizes Commitment to Patient Centricity
The PhRMA Foundation has expanded its vision of the value assessment framework to include health equity and patient centricity. PhRMA [...]
PharmacoEconomics Article Authors Discuss 8 Recommendations for CEAs in Diagnostic Assessments
An article published in PharmacoEconomics details eight recommendations regarding how cost-effectiveness analyses (CEAs) are used in diagnostics. The researchers call [...]
JAMA Network Open Article Highlights the Plight of the Uninsured as Drug Costs Soar
A recent article published in JAMA Network Open highlights one major healthcare spending trend: the uninsured. An increase in concentration [...]
Papa Raises $150 Million in Series D Funding, Seeks to Improve Health Equity
The startup Papa has raised $150 million in series D funding. The company aims to address loneliness by connecting seniors [...]
Panalgo and HealthEconomics.Com Host Webinar on Successful ICER Strategies
Panalgo and HealthEconomics.Com hosted a webinar detailing strategies that lead to successful evaluation by the Institute for Clinical and Economic [...]
Xcenda HEOR Experts Discuss ICER’s UPI Assessments
Xcenda’s Tasmina Hydery and Anne Loos shared their thoughts on the methodologies used by the Institute for Clinical and Economic [...]
HealthVerity’s IPGE RWD Platform Ensures Privacy
The HealthVerity Identity, Privacy, Governance and Exchange (IPGE) Platform offers useable real world data (RWD). The platform was created in [...]
RWD Advances Rare Disease R&D, Brings Hope to Patients
Patient registries are fast becoming a critical source of real world data (RWD), especially in rare disease research and development [...]
Leveraging RWD to Improve Outcomes for Patients With Mantle Cell Lymphoma
A collaboration between Janssen and Flatiron Health led to advancements in the research and care of patients with Mantle Cell [...]
[JAMA Article] New Oncology Drugs Command High Price Tags Despite Lack of Improved Survival
In an article published in JAMA Internal Medicine, researchers assessed the costs of 44 new oncology drugs. Surprisingly, they found [...]
ICER Releases Final Evidence Report for Hypertrophic Cardiomyopathy Drug
The Institute for Clinical and Economic Review (ICER) has published its Final Evidence Report for mavacamten, produced by MyoKardia and [...]
Flatiron ResearchX On-Demand Webinar on RWE in Regulatory Submissions
Flatiron ResearchX invited real world evidence (RWE) and pharma leaders to discuss how RWE impacts submissions to regulatory bodies. Available [...]
eBook on Rare Disease Therapies and Marketing Now Available
Rare Disease Advisor is offering a free eBook on rare disease (RD) trends and marketing efforts. The eBook details highly [...]
Amgen’s Patent Thicket Strategy Yields Billions in Drug Sales for TNF Inhibitor Enbrel
Amgen has employed a powerful strategy to maintain its monopoly on Enbrel, a drug that targets tumor necrosis factor (TNF) [...]
Veradigm Details the Power of Linked Healthcare Data in RWD Research
Sources of real world data (RWD) such as claims data, surveillance data gathered from disease registries, and electronic health record [...]